Dr. Ning Lin, MD

Dr. Lin practices at Eye and Vision Central California, Inc. in Madera, California.

Dr. Lin's NPI, 1821094012, was assigned on June 22, 2005. Dr. Lin graduated from Sun Yat-Sen University of Medical Science in 1982. Dr. Lin holds California license A80829.

Dr. Lin's primary practice is Eye and Vision Central California, Inc., at 2325 W Cleveland Ave, Madera, CA 93637-8753. The practice phone is (559) 674-4700.

Dr. Lin's primary practice is Eye and Vision Central California, Inc. in Madera, California. Dr. Lin is also affiliated with Saint Agnes Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Lin is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Lin's licenses on file in 2 states: California and South Carolina.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, glaucoma and glaucoma surgery among the conditions Dr. Lin treats.

CMS data shows 3,471 Medicare services from Dr. Lin across 20 procedure codes in 2024, for 522 Medicare patients. Medicare paid $218,079 for them.

CMS counts 522 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 72% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 44, with 59% women.

In 2024, Dr. Lin wrote 1,601 Medicare Part D claims for 321 patients. 63% of them were for generic drugs. CMS names the drug for 1,529 of them, across 23 drugs with 11 or more claims each, at $164,722 in total drug cost. In 2023, CMS named 1,489 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Lin for performance year 2024, reported individually. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 110 procedures of cataract surgery by Dr. Lin, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 61 papers to Dr. Lin, published from 2009 to 2019. 2014 was the busiest year, with 11. The most frequent topics are Cerebral Angiography, Intracranial Aneurysm and Embolization, Therapeutic. Dr. Lin has published most often in J Neurosurg. Dr. Lin's most frequent co-authors are Ning Lin, MD, Rose Du, MD, PhD and Adam Michael Brouillard, MBA, MD.

CMS Open Payments shows 40 general payments to Dr. Lin from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Shire North American Group Inc paid the most, $328.

Dmand AI lists 1 award for Dr. Lin.

Dr. Lin graduated from Sun Yat-Sen University of Medical Science in 1982. Dr. Lin is a member of AAO.

Dr. Lin is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.